Gout drugs like allopurinol may also protect against heart disease, study reveals

New research highlights the benefits of urate-lowering drugs for gout patients beyond just easing joint pain. These medications, including allopurinol, may also cut the risk of heart disease. With around 12 million adults in the U.S. affected by gout, the findings could have wide-reaching implications for public health.

Gout is a type of inflammatory arthritis that causes sudden, severe pain and swelling in joints. Over time, high urate levels in the blood can form sharp, needle-shaped crystals in and around joints, leading to flare-ups. Allopurinol works by reducing urate levels and dissolving these crystals, which helps manage symptoms.

The University of Nottingham study analysed data from millions of patients worldwide. It found that keeping serum urate levels below 360 micromol/L not only reduces gout flares but also lowers cardiovascular risks. When levels drop below 300 micromol/L, the protective effect becomes even stronger.

The right dose of allopurinol varies for each person. But when taken correctly, the drug can help prevent heart attacks and strokes in those with gout. Researchers estimate that around 10 million people globally are already taking uric acid-lowering treatments, making the findings particularly relevant.

The study confirms that managing urate levels with medication does more than relieve gout symptoms. It also reduces the risk of serious heart problems. For the millions living with gout, proper treatment could lead to better long-term health outcomes.